Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Mcmorgan & Co. LLC

Mcmorgan & Co. LLC cut its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 30,377 shares of the company’s stock after selling 215 shares during the quarter. Mcmorgan & Co. LLC owned 0.06% of Prestige Consumer Healthcare worth $2,372,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kestra Investment Management LLC purchased a new position in Prestige Consumer Healthcare in the fourth quarter valued at $27,000. CIBC Private Wealth Group LLC boosted its stake in shares of Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock valued at $34,000 after buying an additional 152 shares during the period. Headlands Technologies LLC acquired a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth about $40,000. GAMMA Investing LLC increased its stake in shares of Prestige Consumer Healthcare by 18.9% during the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after buying an additional 220 shares during the period. Finally, Huntington National Bank raised its holdings in Prestige Consumer Healthcare by 133.2% in the fourth quarter. Huntington National Bank now owns 1,481 shares of the company’s stock valued at $116,000 after acquiring an additional 846 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Insider Buying and Selling at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 1,678 shares of the firm’s stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now owns 17,157 shares of the company’s stock, valued at $1,544,130. This trade represents a 8.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have commented on PBH shares. Oppenheimer increased their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. DA Davidson raised their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Canaccord Genuity Group upped their price objective on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. StockNews.com lowered Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, April 8th. Finally, Royal Bank of Canada upped their price target on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a “sector perform” rating in a report on Friday, March 21st. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $93.33.

Prestige Consumer Healthcare Stock Up 0.4 %

Shares of NYSE PBH opened at $80.10 on Friday. The business has a 50-day moving average price of $84.16 and a 200 day moving average price of $80.16. The stock has a market cap of $3.97 billion, a PE ratio of 18.76, a price-to-earnings-growth ratio of 2.69 and a beta of 0.47. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.